FIELD: medicine, dermatology.
SUBSTANCE: it is suggested to apply quingamin in combination with prednisolone. The latter should be prescribed at its average daily dosages, and quingamin daily dosage should be increased for 120-130 mg every 9-11 d beginning from 120-130 mg to reach 450-500 mg/d. Moreover, course dosage of quingamin corresponds to 15-18 mg. The method decreases toxic reactions to quingamin introduction.
EFFECT: higher efficiency of therapy.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF ALCOHOLIC AND NON-ALCOHOLIC STEATOHEPATITIS | 2006 |
|
RU2337365C1 |
| A METHOD FOR ASSESSMENT OF CHRONIC ACTIVE HEPATITIS COURSE WITH CHILDREN | 0 |
|
SU1836638A3 |
| METHOD OF TREATING CHRONIC HEPATIC DISEASES | 0 |
|
SU1821209A1 |
| METHOD OF TREATING ACID-DEPENDENT CONDITIONS ASSOCIATED WITH HELICOBACTER PYLORI | 2011 |
|
RU2446797C1 |
| METHOD FOR PREDICTION OF SEVERITY OF GLOMERULONEPHRITIS | 2014 |
|
RU2583937C1 |
| METHOD OF TREATING OXALATE NEPHROPATHY IN CHILDREN | 2020 |
|
RU2738552C1 |
| WAY OF LABORATORY ESTIMATION OF HOMEOSTASIS CONDITION AT PATIENTS WITH DRUG AND ALCOHOLIC ADDICTION | 2008 |
|
RU2365918C1 |
| METHOD FOR PHARMACOLOGICAL CORRECTION OF ENDOGENOUS INTOXICATION IN CASE OF ACUTE DESTRUCTIVE PANCREATITIS | 2003 |
|
RU2245718C2 |
| METHOD FOR TREATING PATIENTS FOR VIRAL HEPATITIS C | 2002 |
|
RU2212248C1 |
| METHOD FOR TREATING PATIENTS FOR NONSPECIFIC ULCERATING COLITIS | 1999 |
|
RU2200007C2 |
